Ascendis Pharma A/S (ASND)
201.45
+4.82
(+2.45%)
USD |
NASDAQ |
Dec 10, 16:00
201.45
0.00 (0.00%)
After-Hours: 16:48
Ascendis Pharma Market Cap: 12.31B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 40.81M |
| Novo Nordisk A/S | 218.04B |
| DBV Technologies SA | 547.24M |
| Cellectis SA | 512.16M |
| Biodexa Pharmaceuticals Plc | 4.213M |
Market Cap Related Metrics
| PS Ratio | 16.85 |
| Price | 201.45 |
| Earnings Yield | -2.11% |